Dagher R - Search Results

1

Pilot trial of tumor-specific peptide vaccination and continuous infusion interleukin-2 in patients with recurrent Ewing sarcoma and alveolar rhabdomyosarcoma: an inter-institute NIH study.

Dagher R, Long LM, Read EJ, Leitman SF, Carter CS, Tsokos M, Goletz TJ, Avila N, Berzofsky JA, Helman LJ, Mackall CL. Dagher R, et al. Med Pediatr Oncol. 2002 Mar;38(3):158-64. doi: 10.1002/mpo.1303. Med Pediatr Oncol. 2002. PMID: 11836714 Clinical Trial.

2

Molecular confirmation of Ewing sarcoma.

Dagher R, Pham TA, Sorbara L, Kumar S, Long L, Bernstein D, Mackall C, Raffeld M, Tsokos M, Helman L. Dagher R, et al. J Pediatr Hematol Oncol. 2001 May;23(4):221-4. doi: 10.1097/00043426-200105000-00009. J Pediatr Hematol Oncol. 2001. PMID: 11846300 Review.

3

Rhabdomyosarcoma: an overview.

Dagher R, Helman L. Dagher R, et al. Oncologist. 1999;4(1):34-44. Oncologist. 1999. PMID: 10337369 Free article. Review.

4

Randomized trial and pharmacokinetic study of pegfilgrastim versus filgrastim after dose-intensive chemotherapy in young adults and children with sarcomas.

Fox E, Widemann BC, Hawkins DS, Jayaprakash N, Dagher R, Aikin AA, Bernstein D, Long L, Mackall C, Helman L, Steinberg SM, Balis FM. Fox E, et al. Among authors: dagher r. Clin Cancer Res. 2009 Dec 1;15(23):7361-7. doi: 10.1158/1078-0432.CCR-09-0761. Epub 2009 Nov 17. Clin Cancer Res. 2009. PMID: 19920107 Free PMC article. Clinical Trial.

5

High dose chemotherapy with autologous peripheral blood progenitor cell transplantation in an anephric child with multiply recurrent Wilms tumor.

Dagher R, Kreissman S, Robertson KA, Provisor A, Bergstein J, Burke K, Rodman JH, Emanuel D, Smith FO. Dagher R, et al. J Pediatr Hematol Oncol. 1998 Jul-Aug;20(4):357-60. doi: 10.1097/00043426-199807000-00016. J Pediatr Hematol Oncol. 1998. PMID: 9703013

6

The advisory process for anticancer drug regulation: a global perspective.

Farrell AT, Papadouli I, Hori A, Harczy M, Harrison B, Asakura W, Marty M, Dagher R, Pazdur R. Farrell AT, et al. Among authors: dagher r. Ann Oncol. 2006 Jun;17(6):889-96. doi: 10.1093/annonc/mdj099. Epub 2005 Dec 15. Ann Oncol. 2006. PMID: 16357020 Free article. Review.

7

Approval summary: imatinib mesylate in the treatment of metastatic and/or unresectable malignant gastrointestinal stromal tumors.

Dagher R, Cohen M, Williams G, Rothmann M, Gobburu J, Robbie G, Rahman A, Chen G, Staten A, Griebel D, Pazdur R. Dagher R, et al. Clin Cancer Res. 2002 Oct;8(10):3034-8. Clin Cancer Res. 2002. PMID: 12374669 Clinical Trial.

8

Approval summary: Docetaxel in combination with prednisone for the treatment of androgen-independent hormone-refractory prostate cancer.

Dagher R, Li N, Abraham S, Rahman A, Sridhara R, Pazdur R. Dagher R, et al. Clin Cancer Res. 2004 Dec 15;10(24):8147-51. doi: 10.1158/1078-0432.CCR-04-1402. Clin Cancer Res. 2004. PMID: 15623588 Clinical Trial.

9

Liposomal doxorubicin in combination with bortezomib for relapsed or refractory multiple myeloma.

Ning YM, He K, Dagher R, Sridhara R, Farrell AT, Justice R, Pazdur R. Ning YM, et al. Among authors: dagher r. Oncology (Williston Park). 2007 Nov;21(12):1503-8; discussion 1511, 1513, 1516 passim. Oncology (Williston Park). 2007. PMID: 18077994 Free article. Clinical Trial.

10

Topotecan in combination with cisplatin for the treatment of stage IVB, recurrent, or persistent cervical cancer.

Brave M, Dagher R, Farrell A, Abraham S, Ramchandani R, Gobburu J, Booth B, Jiang X, Sridhara R, Justice R, Pazdur R. Brave M, et al. Among authors: dagher r. Oncology (Williston Park). 2006 Oct;20(11):1401-4, 1410; discussion 1410-11, 1415-6. Oncology (Williston Park). 2006. PMID: 17112001 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

119 results

Search Page